134 results
424B3
CYCC
Cyclacel Pharmaceuticals Inc
14 Feb 24
Prospectus supplement
4:06pm
potential drugs.
If a supplier upon whom we rely fails to produce on a timely basis the finished goods in the volumes that we require or fails to meet … such products could substantially decline. As the third-party manufacturers are the sole supplier of the products, any delays may impact our sales.
In all
8-K
EX-10.1
h9t3 orrw4z960
22 Dec 20
Cyclacel Pharmaceuticals ANNOUNCES At-the-market $7 MILLION strategic INVESTMENT BY FUNDAMENTAL INVESTOR ACORN BIOVENTURES
4:05pm
424B4
d2zxqt9tbtuym6i2r4r
21 Jul 17
Prospectus supplement with pricing info
12:00am